Kadcyla (ado-trastuzumab emtansine) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Kadcyla is used to treat HER2-positive breast cancer.
Kadcyla is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic).
Kadcyla is usually given after other cancer medications have been tried without success.
Kadcyla should not be used in place of Herceptin (trastuzumab).
